AngioDynamics Company Profile (NASDAQ:ANGO)

About AngioDynamics

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ANGO
  • CUSIP: 03475V10
Key Metrics:
  • Previous Close: $16.54
  • 50 Day Moving Average: $16.62
  • 200 Day Moving Average: $16.64
  • 52-Week Range: $36,504,000.00 - $10.44
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 22.05
  • P/E Growth: 1.58
  • Market Cap: $603.78M
  • Outstanding Shares: 36,504,000
  • Beta: 1.02
Profitability:
  • Net Margins: -7.91%
  • Return on Equity: 4.87%
  • Return on Assets: 3.49%
Debt:
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 2.91%
  • Quick Ratio: 1.80%
Additional Links:
Companies Related to AngioDynamics:

Analyst Ratings

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $16.70 (0.97% upside)

Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
Show:
DateFirmActionRatingPrice TargetDetails
2/8/2017Barclays PLCInitiated CoverageEqual Weight$17.00View Rating Details
1/23/2017Canaccord GenuityReiterated RatingHold$17.50View Rating Details
12/27/2016Cantor FitzgeraldReiterated RatingBuy$19.00View Rating Details
9/12/2016KeyCorpSet Price TargetBuy$18.00View Rating Details
4/8/2016Piper Jaffray CompaniesInitiated CoverageNeutral$12.00View Rating Details
11/10/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
9/23/2015SidotiInitiated CoverageNeutral$14.50View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for AngioDynamics (NASDAQ:ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/5/2017        
1/6/2017Q217$0.16$0.19$89.00 millionViewListenView Earnings Details
10/5/2016Q117$0.13$0.17$88.10 millionViewN/AView Earnings Details
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.16$0.12$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
Current Year EPS Consensus Estimate: $0.67 EPS
Next Year EPS Consensus Estimate: $0.75 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.12$0.15$0.14
Q2 20162$0.16$0.17$0.17
Q1 20171$0.13$0.13$0.13
Q2 20171$0.17$0.17$0.17
Q3 20172$0.15$0.16$0.16
Q4 20172$0.14$0.16$0.15
Q1 20181$0.18$0.18$0.18
Q2 20181$0.15$0.15$0.15
Q3 20181$0.23$0.23$0.23
Q4 20181$0.22$0.22$0.22
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AngioDynamics (NASDAQ:ANGO)
Insider Ownership Percentage: 1.88%
Institutional Ownership Percentage: 79.52%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.00View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AngioDynamics (NASDAQ:ANGO)
DateHeadline
News IconAngioDynamics Inc ANGO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ANGO)
www.bioportfolio.com - February 16 at 8:26 AM
finance.yahoo.com logoCoverage initiated on AngioDynamics by Barclays (NASDAQ:ANGO)
finance.yahoo.com - February 8 at 8:47 PM
marketexclusive.com logoAnalyst Activity – Barclays PLC Initiates Coverage On AngioDynamics (NASDAQ:ANGO) With a Equal Weight (NASDAQ:ANGO)
marketexclusive.com - February 8 at 3:47 PM
marketexclusive.com logoAnalyst Activity – Barclays PLC Initiates Coverage On AngioDynamics (NASDAQ:ANGO) With a Equal Weight (NASDAQ:ANGO)
marketexclusive.com - February 8 at 3:47 PM
capitalcube.com logoAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : January 20, 2017 (NASDAQ:ANGO)
www.capitalcube.com - January 20 at 3:38 PM
capitalcube.com logoETFs with exposure to AngioDynamics, Inc. : January 19, 2017 (NASDAQ:ANGO)
www.capitalcube.com - January 19 at 4:05 PM
capitalcube.com logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017 (NASDAQ:ANGO)
www.capitalcube.com - January 17 at 10:01 AM
finance.yahoo.com logoANGIODYNAMICS INC Financials (NASDAQ:ANGO)
finance.yahoo.com - January 12 at 3:35 PM
finance.yahoo.com logoPost Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% (NASDAQ:ANGO)
finance.yahoo.com - January 11 at 3:25 PM
biz.yahoo.com logoANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ANGO)
biz.yahoo.com - January 10 at 3:35 PM
News IconSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Dut... (NASDAQ:ANGO)
ih.advfn.com - January 10 at 1:48 AM
marketexclusive.com logoAnalyst Activity – Canaccord Genuity Reiterates Hold on AngioDynamics (NASDAQ:ANGO) (NASDAQ:ANGO)
marketexclusive.com - January 8 at 8:30 PM
us.rd.yahoo.com logo6:14 am AngioDynamics beats by $0.03, misses on revs; raises FY17 EPS in-line, reaffirms FY17 revs guidance (NASDAQ:ANGO)
us.rd.yahoo.com - January 7 at 1:41 AM
finance.yahoo.com logoEdited Transcript of ANGO earnings conference call or presentation 6-Jan-17 1:00pm GMT (NASDAQ:ANGO)
finance.yahoo.com - January 6 at 8:40 PM
News IconVerizon Casts Doubt on Yahoo Acquisition, Ruby Tuesday Tumbles (NASDAQ:ANGO)
www.ticker.com - January 6 at 3:39 PM
News IconPriceSmart Net Jumps; AZZ, Greenbrier Net Decline (NASDAQ:ANGO)
www.123jump.com - January 6 at 3:39 PM
baystreet.ca logoAngioDynamics (ANGO) Down on Earnings Estimates (NASDAQ:ANGO)
www.baystreet.ca - January 6 at 3:39 PM
cnbc.com logoAngioDynamics beats 2Q profit forecasts (NASDAQ:ANGO)
www.cnbc.com - January 6 at 3:39 PM
publicnow.com logoAngioDynamics Reports Fiscal 2017 Second Quarter Results (NASDAQ:ANGO)
www.publicnow.com - January 6 at 3:38 PM
biz.yahoo.com logoQ2 2017 AngioDynamics Inc Earnings Release - Before Market Open (NASDAQ:ANGO)
biz.yahoo.com - January 6 at 3:38 PM
biz.yahoo.com logoANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit (NASDAQ:ANGO)
biz.yahoo.com - January 6 at 3:38 PM
seekingalpha.com logoAngioDynamics non-GAAP EPS up 36% in FQ2; updates guidance (NASDAQ:ANGO)
seekingalpha.com - January 6 at 6:36 AM
finance.yahoo.com logoAngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:ANGO)
finance.yahoo.com - January 3 at 8:06 AM
News IconInvestor Wire: Keeping an Eye on AngioDynamics, Inc. (NASDAQ:ANGO) - Wall Street Beacon (NASDAQ:ANGO)
wsbeacon.com - December 30 at 3:50 PM
News IconEnterprise Value Check for AngioDynamics, Inc. (NASDAQ:ANGO) - Wall Street Beacon (NASDAQ:ANGO)
wsbeacon.com - December 27 at 7:31 AM
News IconChecking ROIC Numbers for AngioDynamics, Inc. (NASDAQ:ANGO) - Wall Street Beacon (NASDAQ:ANGO)
wsbeacon.com - December 26 at 7:52 AM
News IconShares in Focus: AngioDynamics, Inc. (NASDAQ:ANGO) - Wall Street Beacon (NASDAQ:ANGO)
wsbeacon.com - December 23 at 3:38 PM
News IconInvestor Technical Review for AngioDynamics Inc. (ANGO) - StockTalk Daily (NASDAQ:ANGO)
stocktalkdaily.com - December 21 at 9:12 PM
News IconCompany Shares in Review: AngioDynamics, Inc. (NASDAQ:ANGO) - OIB News (NASDAQ:ANGO)
oibnews.com - December 21 at 9:12 PM
News IconStock Spotlight: Checking on Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - OIB News (NASDAQ:ANGO)
oibnews.com - December 20 at 8:41 AM
globenewswire.com logoAngioDynamics to Report Fiscal 2017 Second Quarter Financial Results - GlobeNewswire (press release) (NASDAQ:ANGO)
globenewswire.com - December 20 at 8:41 AM
News IconUpdate on Valuation Formula's For AngioDynamics, Inc. (NASDAQ:ANGO) - Marion Business Daily (NASDAQ:ANGO)
marionbusinessdaily.com - December 20 at 8:41 AM
publicnow.com logoAngioDynamics to Report Fiscal 2017 Second Quarter Financial Results (NASDAQ:ANGO)
www.publicnow.com - December 20 at 8:41 AM
News IconInvestor Chatter: Looking at Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Liberty News (NASDAQ:ANGO)
libertynewsrecord.com - December 18 at 3:33 PM
News IconFCF Score Check on Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Marion Business Daily (NASDAQ:ANGO)
marionbusinessdaily.com - December 18 at 3:33 PM
News IconEquity Review: Looking Closer at Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Business Daily Leader (NASDAQ:ANGO)
businessdailyleader.com - December 17 at 8:35 PM
News IconVC Score In Focus for AngioDynamics, Inc. (NASDAQ:ANGO) - The Business Journal (NASDAQ:ANGO)
belmontbusinessjournal.com - December 17 at 3:33 PM
News IconInvestor Review: Focusing in on Shares of AngioDynamics Inc. (ANGO) - StockTalk Daily (NASDAQ:ANGO)
stocktalkdaily.com - December 16 at 3:38 PM
News IconMarket Scope: Taking a Look at AngioDynamics, Inc. (NASDAQ:ANGO) - Business Daily Leader (NASDAQ:ANGO)
businessdailyleader.com - December 16 at 3:38 PM
investornewswire.com logoSentiments And Ratings Alert: AngioDynamics, Inc. (NASDAQ:ANGO) - Investor Newswire (NASDAQ:ANGO)
www.investornewswire.com - December 15 at 9:00 PM
News IconInvestor Radar: Focusing in on Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Wall Street Beacon (NASDAQ:ANGO)
wsbeacon.com - December 15 at 3:59 PM
News IconInvestor Corner: Checking the Numbers for AngioDynamics, Inc. (NASDAQ:ANGO) - Liberty News (NASDAQ:ANGO)
libertynewsrecord.com - December 14 at 3:53 PM
News IconTechnical Buzz on AngioDynamics, Inc. (NASDAQ:ANGO) - Marion Business Daily (NASDAQ:ANGO)
marionbusinessdaily.com - December 14 at 3:53 PM
News IconStock Tracker: Focusing on Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Wall Street Beacon (NASDAQ:ANGO)
wsbeacon.com - December 13 at 8:38 PM
News IconIndicators in Focus on AngioDynamics, Inc. (NASDAQ:ANGO ... - The Business Journal (NASDAQ:ANGO)
belmontbusinessjournal.com - December 13 at 3:37 PM
News IconCompany in Focus: AngioDynamics, Inc. (NASDAQ:ANGO) - Liberty News (NASDAQ:ANGO)
libertynewsrecord.com - December 13 at 1:43 AM
News IconTracking Technical Levels on Shares of AngioDynamics Inc. (ANGO) - StockTalk Daily (NASDAQ:ANGO)
stocktalkdaily.com - December 12 at 3:40 PM
News IconInvestor Circle: Watching the Numbers on Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - The Business Journal (NASDAQ:ANGO)
belmontbusinessjournal.com - December 12 at 7:17 AM
capitalcube.com logoAngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : December 9, 2016 (NASDAQ:ANGO)
www.capitalcube.com - December 9 at 3:36 PM
capitalcube.com logoAngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : December 8, 2016 (NASDAQ:ANGO)
us.rd.yahoo.com - December 9 at 1:50 AM

Social

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

Where is AngioDynamics' stock going? Where will AngioDynamics' stock price be in 2017?

5 equities research analysts have issued 12 month price targets for AngioDynamics' stock. Their predictions range from $12.00 to $19.00. On average, they anticipate AngioDynamics' share price to reach $16.70 in the next twelve months.

When will AngioDynamics announce their earnings?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Wednesday, April, 5th 2017.

What are analysts saying about AngioDynamics stock?

Here are some recent quotes from research analysts about AngioDynamics stock:

  • According to Zacks Investment Research, "AngioDynamics reported a mixed second quarter of fiscal 2017, wherein adjusted earnings surpassed the Zacks Consensus Estimate while revenues missed the same. Meanwhile, over the last three months, AngioDynamics has outperformed the broader industry in terms of price. The company has also provided positive earnings guidance for fiscal 2017. Notably, the major growth drivers for the company are the Perpheral Vascular, the NanoKnife and BioFlo Midline product lines. Meanwhile, the discontinuity of the Celerity tip location program under its vascular segment might dent operational efficiency over the long haul. A sluggish capital spending environment is adversely affecting AngioDynamics’ top-line growth. AngioDynamics is exposed to a stringent regulatory environment. Regulatory setbacks might dampen approvals for pipeline products, which will in turn hurt overall growth." (1/11/2017)

  • Cantor Fitzgerald analysts commented, "We remain confident in our above-consensus F2Q17 adjusted EPS estimate. We are modeling revenues of $91.1M, in line with FactSet consensus of $91.1M, but we have a slightly higher margin outlook than the Street, which we believe should support our adjusted EPS estimate of $0.17, slightly above consensus of $0.16." (12/27/2016)

  • KeyCorp analysts commented, "The initiation of the PIII for ONS-3010 in psoriasis has been delayed slightly to 2016 from 3Q16. The PIII design has been agreed to by FDA and EMA and the interchangeability study design has been discussed with the FDA. The company continues to seek partnerships in the interim to fund its pipeline programs. ONS-3010 Development Stalling: Mgmt plans to initiate the PIII interchangeability trial with first patient enrolled by end of this month/early October w/ initial patient enrollment in EU/Canada and with patient enrollment in U.S. expected to start in early Jan 2017. We note that mgmt stated the FDA and EMA signed off on a PIII trial design and the company basically needs to submit an IND detailing the pre-agreed plan." (9/12/2016)

Who owns AngioDynamics stock?

AngioDynamics' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.53%), Broadfin Capital LLC (4.03%), FMR LLC (3.12%), Numeric Investors LLC (2.41%), State Street Corp (2.20%) and Systematic Financial Management LP (2.15%). Company insiders that own AngioDynamics stock include Avista Capital Partners Gp, Ll, Charles R Greiner, David F Burgstahler and Stephen A Trowbridge.

Who sold AngioDynamics stock? Who is selling AngioDynamics stock?

AngioDynamics' stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, Systematic Financial Management LP, Oxford Asset Management, Tudor Investment Corp Et Al, Menta Capital LLC, Renaissance Technologies LLC, Carleon Capital Partners LLC and Teton Advisors Inc.. Company insiders that have sold AngioDynamics stock in the last year include Avista Capital Partners Gp, Ll, Charles R Greiner, David F Burgstahler and Stephen A Trowbridge.

Who bought AngioDynamics stock? Who is buying AngioDynamics stock?

AngioDynamics' stock was purchased by a variety of institutional investors in the last quarter, including Numeric Investors LLC, Partners Group Holding AG, Russell Investments Group Ltd., Bogle Investment Management L P DE, State Street Corp, Two Sigma Investments LP, Thrivent Financial for Lutherans and Martingale Asset Management L P.

How do I buy AngioDynamics stock?

Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of AngioDynamics stock cost?

One share of AngioDynamics stock can currently be purchased for approximately $16.54.

AngioDynamics (NASDAQ:ANGO) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Earnings History Chart

Earnings by Quarter for AngioDynamics (NASDAQ:ANGO)

Dividend History Chart

Dividend Payments by Quarter for AngioDynamics (NASDAQ:ANGO)

Last Updated on 2/26/2017 by MarketBeat.com Staff